A Multicenter, Open-label Study to Evaluate Ovarian Follicular Activity and Hormone Levels With the Oral Contraceptive Regimen DR-102 Compared to Two 28-day Oral Contraceptive Regimens Containing Different Synthetic Progestins.
Phase of Trial: Phase I
Latest Information Update: 20 Aug 2013
At a glance
- Drugs Ethinylestradiol/desogestrel (Primary) ; Drospirenone/ethinylestradiol; Ethinylestradiol; Ethinylestradiol/levonorgestrel
- Indications Pregnancy
- Focus Pharmacodynamics
- 28 May 2013 Status changed from active, no longer recruiting to completed, based on 61st ACOG abstract.
- 08 May 2013 Results presented at the 61st Annual Clinical Meeting of the American College of Obstetricians and Gynecologists.
- 08 May 2013 Results were presented at the 61st Annual Clinical Meeting of the American Congress of Obstetricians and Gynecologists (ACOG), according to a Teva Women's Health media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History